Cargando…
Overexpression of HHLA2, a member of the B7 family, is associated with worse survival in human colorectal carcinoma
BACKGROUND: Colorectal carcinoma (CRC) is one of the most common malignancies, and immunotherapy has opened a new field of cancer treatment in recent years. Generally, CRC does not benefit from immunotherapy. HHLA2, a member of the B7 family, is a novel immune checkpoint molecule, and the prognostic...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865557/ https://www.ncbi.nlm.nih.gov/pubmed/29593422 http://dx.doi.org/10.2147/OTT.S160493 |